TEZUME

Swiss trademark · 602019 · Word mark · Deleted

Register entry

Registration number
602019
Application number
53522/2010
Status
Deleted
Type
Word mark
Filed
Apr 9, 2010
Registered
Jun 21, 2010
Published
Jun 21, 2010
Deleted
Nov 3, 2020
Reason
Not renewed
Priority
09.10.2009 US
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung von Diabetes; pharmazeutische Präparate für die Behandlung von rheumatischer Arthritis; pharmazeutische Präparate für die Behandlung der Crohn-Krankheit; pharmazeutische Präparate für die Behandlung von Psoriasis; pharmazeutische Präparate für die Behandlung von autoimmunen Störungen und Krankheiten; pharmazeutische Präparate für die Behandlung von Krebs.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 3, 2020

    Deleted, not renewed

    Published in Swissreg on 03.11.2020

  2. Aug 10, 2011

    Transferred

    Owner
    Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA → MacroGenics, Inc., 1500 East Gude Drive, Rockville, MD 20850, USA

    Published in Swissreg on 10.08.2011

  3. Jun 21, 2010

    Registered

    Published in Swissreg on 21.06.2010

Parties

Holder

MacroGenics, Inc.

1500 East Gude Drive, Rockville, MD 20850, US

Agent

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.